Associations of stunting in early childhood with cardiometabolic risk factors in adulthood

Abstract

Early life stunting may have long-term effects on body composition, resulting in obesity-related comorbidities. We tested the hypothesis that individuals stunted in early childhood may be at higher cardiometabolic risk later in adulthood. 1753 men and 1781 women participating in the 1982 Pelotas (Brazil) birth cohort study had measurements of anthropometry, body composition, lipids, glucose, blood pressure, and other cardiometabolic traits at age 30 years. Early stunting was defined as height-for-age Z-score at age 2 years below -2 against the World Health Organization growth standards. Linear regression models were performed controlling for sex, maternal race/ethnicity, family income at birth, and birthweight. Analyses were stratified by sex when p-interaction<0.05. Stunted individuals were shorter (β = -0.71 s.d.; 95% CI: -0.78 to -0.64), had lower BMI (β = -0.14 s.d.; 95%CI: -0.25 to -0.03), fat mass (β = -0.28 s.d.; 95%CI: -0.38 to -0.17), SAFT (β = -0.16 s.d.; 95%CI: -0.26 to -0.06), systolic (β = -0.12 s.d.; 95%CI: -0.21 to -0.02) and diastolic blood pressure (β = -0.11 s.d.; 95%CI: -0.22 to -0.01), and higher VFT/SAFT ratio (β = 0.15 s.d.; 95%CI: 0.06 to 0.24), in comparison with non-stunted individuals. In addition, early stunting was associated with lower fat free mass in both men (β = -0.39 s.d.; 95%CI: -0.47 to -0.31) and women (β = -0.37 s.d.; 95%CI: -0.46 to -0.29) after adjustment for potential confounders. Our results suggest that early stunting has implications on attained height, body composition and blood pressure. The apparent tendency of stunted individuals to accumulate less fat-free mass and subcutaneous fat might predispose them towards increased metabolic risks in later life.

About the Authors:

Emanuella De Lucia Rolfe

Contributed equally to this work with: Emanuella De Lucia Rolfe, Giovanny Vinícius Araújo de França

Roles Conceptualization, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

* E-mail: [email protected]

Affiliation: Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, United Kingdom

ORCID http://orcid.org/0000-0003-3542-2767

Giovanny Vinícius Araújo de França

Contributed equally to this work with: Emanuella De Lucia Rolfe, Giovanny Vinícius Araújo de França

Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

Affiliation: Post-graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil

Carolina Avila Vianna

Roles Data curation, Methodology, Resources, Writing – review & editing

Affiliation: Post-graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil

Denise P. Gigante

Roles Funding acquisition, Writing – review & editing

Affiliation: Post-graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil

J. Jaime Miranda

Roles Conceptualization, Writing – review & editing

Affiliation: Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru

John S. Yudkin

Roles Writing – review & editing

Affiliation: University College London, London, United Kingdom

Bernardo Lessa Horta

Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing

Affiliation: Post-graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil

Ken K. Ong

Roles Conceptualization, Supervision, Writing – review & editing

Affiliation: Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, United Kingdom

Introduction

The prevalence of obesity is rapidly increasing worldwide, particularly affecting low and middle-income countries, where this condition co-exists with undernutrition.[1,2] Childhood stunting is a significant global health issue, affecting 161 million children under 5 years of age in 2013.[3] It has a complex aetiology, involving household, environmental, socioeconomic and cultural factors.[4] Research has suggested that stunting or poor height gain in early childhood may be a critical factor in promoting later obesity and obesity-related comorbidities.[2,5,6]

Although the prevalence of stunting in the last decades has significantly decreased in middle income countries, it remains a global health priority due to its long-term consequences. In Brazil, national data show a reduction in the prevalence of childhood stunting from 37% in 1974–1975 to 7% in 2006–2007 [7], and in the city of Pelotas, a city in Southern Brazil, from 13.9% in 1982 to 5% in 2004.[8]

A systematic review by The Maternal and Child Undernutrition Study Group [9], which included cohort studies from five low- and middle-income countries (Brazil—The 1982 Pelotas birth cohort, Guatemala, India, the Philippines, and South Africa) has shown that poor growth early in life has longer-term consequences, such as shorter adult height, lower attained schooling, reduced adult income, and decreased offspring birthweight.

Currently, findings on the association of early stunting with later adiposity are controversial. In Guatemalan individuals, early stunting was associated with greater central adiposity after adjustment for overall fatness and potential confounders; however, studies in adults from New Delhi and Jamaican young adults failed to find evidence of an association between previous stunting and total or central adiposity. In addition, children who were undernourished in the first 2 years of life and gained weight rapidly later in childhood and adolescence were at a greater risk of obesity-related disease as they presented an unfavourable metabolic profile, including increased glucose concentrations, higher blood pressure and harmful lipid profiles.

Evidence from the prospective British 1946 Birth Cohort Study indicated a substantial effect of stunting in mid-childhood on higher mortality 30 to 60 years later.[10] The effects of stunting seemed also to influence the next generation, as women who were themselves stunted in childhood had a tendency to have stunted offspring.[11] Furthermore, early stunting seemed to be related to lower intelligence quotient, achieved schooling and income at 30 years of age.[12]

Previous analyses from the 1982 Pelotas (Brazil) birth cohort, however, failed to find evidence of associations of early stunting with metabolic syndrome components in young adults (mean age 22.8 years).[13] These inconsistencies may be partly explained by the different methods used to assess body composition. Most of these epidemiological studies relied on estimates of body fat and fat distribution from standard anthropometry.

Using data from the same cohort at age 30 years, we previously showed that men and women with early life stunting had lower subcutaneous abdominal fat thickness (SAFT), measured by the imaging technique ultrasound, but not visceral fat thickness (VFT) than other individuals.[14] In the present study, we now expanded on those analyses, focusing on the associations of early stunting with a wider range and more robust measurements of cardiometabolic traits in adulthood. We hypothesised that adults who were stunted in early childhood would have an unfavourable body composition and worse metabolic profile than those who did not experience stunting in early life.

Materials and methods

Study design and population

Details of the 1982 Pelotas Birth Cohort Study have been previously published elsewhere. [15–17] Briefly, it recruited 5914 live births in 1982 to mothers living in the urban part of Pelotas, a Southern Brazil city. The study participants have been followed up and examined at different times/phases. The most recent follow up was carried out in 2012–2013, which included a total of 3711 cohort members representing 68.1% of the original sample, including 325 members known to have died. In the current analysis, we included 3534 individuals, 1753 men and 1781 women, who had complete information on early stunting and selected cardiometabolic traits at age 30 years.[18]

In the early phases, verbal informed consent was obtained from the mothers, while in recent phases; written consent was obtained from each participant. The study was approved by the Ethical Committee of the Federal University of Pelotas and performed in accordance with the Declaration of Helsinki. The exclusion criteria for the ultrasound examination in the 2012–13 phase of the Pelotas study included pregnancy or probable pregnancy, as well as have given birth in the three months prior to the examination.

Study measurements

Anthropometry and body composition.

Measurements were performed by trained staff following standard protocols. Adults’ weight was recorded to the nearest 0.1 kg using calibrated electronic scales (TANITA BC-418 MA; Tanita, Tokyo, Japan). Supine length and height was measured to the nearest 0.1cm in 1984 and 2013, respectively, using boards manufactured locally according to international specifications (AHRTAG; Healthlink Worldwide, London, UK). Adults’ height was measured to the nearest 0.1cm using a wall-mounted stadiometer (SECA 240; Seca, Birmingham, UK). Early stunting was defined as height-for-age Z-score below -2 at age 2 years using the World Health Organization (WHO) criteria [19]. Body mass index (BMI; in kg/m²) was calculated as weight divided by square height.Fat mass (kg) fat free mass (kg) were derived using the air-displacement plethysmography (Bod Pod^®, Cosmed, Concord, CA USA). Body density was firstly calculated as mass/body volume and body fat percentage was estimated using the Siri equation.[20]

A Toshiba Xario (Toshiba Medical Systems Corporation, Tochigi-ken, Japan) ultrasound machine with a 3.5-MHz convex transducer was used to derive visceral and subcutaneous (total, deep and superficial) abdominal fat thicknesses. VFT was estimated by the distance between the peritoneum and the lumbar spine and SAFT was defined as the distance between the posterior line of dermis to the linea alba. Both measurements were obtained at the intersection between the xyphoid line and the waist circumference. The relative intra-observer technical error of measurement for the visceral thickness was 4.1% and 3.4% for subcutaneous fat thickness, whereas the relative inter-observer technical error of measurement was 3.1% for both measurements.

Biochemistry and clinical measurements.

Non-fasting blood samples were collected by venous puncture. Whole blood samples were spotted onto filter paper (Whatman 903; Maidstone, UK), air-dried, and stored in sealed envelopes at ambient temperature. Random glucose was measured by an automatic enzymatic colorimetric method. Glycated haemoglobin (HbA1c) was measured by the Variant (Bio-Rad, Hercules, CA) ion-exchange high-performance liquid chromatography (HPLC) method. High sensitive C reactive protein was analysed using immune-turbidimetry test with intra-inter assay coefficient of variation of 4.2%.

Blood lipids (total cholesterol, high and low-density lipoprotein and triglycerides) were measured by standard enzymatic methods. All the above analyses were run in an automated Mindray BS 380 Chemistry Analyser (Shenzhen Mindray Bio-Medical Electronics Co., Ltd, China).

Carotid intima-media thickness (CIMT) was measured with a Toshiba Xario (Toshiba Medical Systems Corp) ultrasound machine with a 3.5-MHz linear transducer. CIMT was measured at the posterior wall of the right and left common carotid arteries in longitudinal planes, through an image of a 10-mm long section proximal to the carotid bulb. The image were analysed using the Carotid Analyser for Research (Medical Imaging Applications, MIA-LLC), which automatically calculated the mean value of 90 measurements (frames) taken [21].

Arterial blood pressure was measured twice (at the beginning and end of the examination) with an automated blood pressure monitor (Omron HEM-705CPINT) with the participant rested and seated for at least five minutes.

Other covariates.

Information on a priori potential confounders was collected. Family income in 1982 was calculated as the sum of the monthly incomes of all working persons living in the household, expressed in multiples of the minimum wage (≤1/1.1-3/3.1–6; >6). Maternal self-reported skin colour was collected as a marker of race/ethnicity and categorized into two groups (white/non-white). Birthweight was measured to the nearest 10g using calibrated paediatric scales (Filizola, São Paulo, Brazil) by trained anthropometrists following standard protocols.

Statistical analysis

Statistical analyses were performed with Stata (version 13; StataCorp, College Station, TX). Descriptive data are presented as mean ± standard deviation (s.d.) or median and interquartile range. Inter-correlations between the independent variables were assessed by Spearman’s correlation. All outcomes were log-transformed to achieve normal distributions, and were posteriorly standardized to allow direct comparisons of the regression coefficients. Therefore, the Beta (β) coefficients indicate the standardised difference in the outcomes comparing stunted versus non-stunted individuals.

Inter-correlations between the independent variables were assessed by Spearman’s correlation. Co-linearity between parameters was indicated by a variance inflation factor (VIF) > 5.

Linear regression models were derived to analyse the relationship between stunting at age 2 years (exposure) and the various body composition and the metabolic traits variables (outcomes). We initially tested whether sex modified the association of stunting at age 2 years with each outcome at age 30 years, and presented the analyses stratified by sex when p-interaction<0.05. For each outcome, we ran crude models (including only the outcome and stunting at age 2 years), as well as models adjusted for potential confounders measured at birth (sex, maternal race/ethnicity, family income at birth, and birthweight). We also assessed the association between stunting at age 2 years and VFT adjusting for potential confounders and current BMI, for comparative purposes. Additional inverse-probability weighted models were applied, which account for possible selection bias in cohort follow-up.

We applied inverse-probability weighting (IPW) [22] to take into account selection bias by using the teffects ipw command in Stata. For comparative purposes, IPW models were adjusted separately for each outcome, including the same potential confounders used in the linear regression models. The 95% confidence intervals (CI) were estimated using the jackknife method. A 5% significance level was applied.

Results

Characteristics of the study population are summarised in Table 1. The mean age of the participants was 30.20years (s.d. = 0.34). Men had greater length at 2 years, attained height at 30 years of age, weight, BMI, fat-free mass, VFT, systolic and diastolic blood pressure, random glucose level, total and low-density lipoprotein (LDL), and triglycerides, but lower fat mass, subcutaneous abdominal fat, C-reactive protein, and high-density lipoproteins (HDL) than women at age 30 years.

[Figure omitted. See PDF.]

Table 1. Characteristics of the study sample.

https://doi.org/10.1371/journal.pone.0192196.t001

Stunting at age 2 years was more prevalent in men than in women (16.3% and 11.6%, respectively). It was higher, almost double, amongst black individuals than whites, and it was much higher, six to ten times more, among those in the poorest families relative to those in the highest income category (Table 2).

[Figure omitted. See PDF.]

Table 2. Stunting at age 2 years by covariates.

https://doi.org/10.1371/journal.pone.0192196.t002

The correlations between the independent variables are shown in Table 3.

[Figure omitted. See PDF.]

Table 3. Correlation (Spearman’s ρ) between the independent variables.

https://doi.org/10.1371/journal.pone.0192196.t003

Associations of stunting at age 2 years with cardiometabolic traits at age 30 years are shown in Table 4. In the crude models, stunting at 2 years was associated with lower adult height, current BMI, fat-mass, and total SAFT, and with higher VFT, VFT/SAFT ratio and random glucose concentration. After adjustment for potential confounders, stunted individuals were shorter (β = -0.71 s.d.; p<0.001); had lower BMI (β = -0.14 s.d.; p = 0.01), fat mass (β = -0.28 s.d.; p<0.001), SAFT (β = -0.16 s.d.; p = 0.002), systolic blood pressure (β = -0.12 s.d.; p = 0.01), and diastolic blood pressure (β = -0.11 s.d.; p = 0.04); and higher VFT/SAFT ratio (β = 0.15 s.d.; p = 0.001), in comparison with non-stunted individuals. Higher visceral fat thickness (β = 0.08 s.d.; p = 0.04) in stunted individuals at 2 years only appeared after adjustment for current BMI.

[Figure omitted. See PDF.]

Table 4. Associations of stunting at age 2 years with cardiometabolic traits at age 30 years.

https://doi.org/10.1371/journal.pone.0192196.t004

Table 5 presents sex-specific analyses performed for those outcomes in which sex modification was identified (p-interaction<0.05). After adjustment for potential confounders, early stunting was associated with lower fat free mass in both men (β = -0.39 s.d.; p<0.001) and women (β = -0.37 s.d.; p<0.001). Additional inverse-probability weighted models showed essentially similar associations (S1 and S2 Tables).

[Figure omitted. See PDF.]

Table 5. Associations of stunting at age 2 years with glycated haemglobin, total cholesterol and HDL cholesterol, and fat free mass at age 30 years by sex.

https://doi.org/10.1371/journal.pone.0192196.t005

Discussion

Our results from this large, long-running, middle-income country birth cohort study suggest that stunting at age 2 years has implications on attained height, body composition and blood pressure. Consistently with the current literature, we observed that men and women with early stunting were shorter as adults than non-stunted individuals.

Central obesity has been reported to be greater in stunted individuals who were undernourished in childhood, born in Jamaica in the 1970, and in 1986.[23–25] However, most of these studies relied on anthropometric indicators of body fat, such as waist and hip circumferences and skinfold thickness, rather than directly assessed specific fat compartments, such as visceral and subcutaneous fat, given that the distribution of these fat compartments may have different metabolic consequences. Visceral fat has been associated with a low-grade inflammation due to the increased secretion of numerous pro-inflammatory cytokines, which may play an important role in many diseases, promoting angiogenesis, inflammation, cell proliferation, and insulin resistance.[26–28] Although some studies have shown that subcutaneous fat may have an independent antiatherogenic effect, others have suggested that it might be a significant predictor of adverse metabolic consequences in some populations.[29,30] In our study, we found an association between early stunting and higher visceral fat accumulation in adulthood only after adjustments for current BMI. In addition, our findings also suggest that early stunting may decrease lean mass, subcutaneous abdominal fat accumulation, as well as total body fat mass.

Childhood stunting may lead to less lean mass as individuals who are undernourished tend to use up protein stores in the muscle as a source of energy as a consequence of inadequate energy intake[31]. Muscle tissue catabolism is significantly greater during protein–energy malnutrition and results in the reduction in the muscle mass in those individuals [32]. The loss of subcutaneous fat may also be a result of insufficient food intake that is deficient of calories and protein. Reduction in subcutaneous fat is often seen in children with marasmus [33,34]. An important characteristic of marasmus is growth failure, which results in those children not reaching their full potential height (stunted). While, children with kwashiorkor retain subcutaneous fat as calorie intake is adequate but are protein deficient [33,34].

This body composition profile resulting from stunting might be harmful in relation to metabolic disorders. Lean mass is the largest insulin-sensitive tissue in the body and plays a pivotal role in the maintenance of glucose metabolism.[35,36] Loss or reduced lean mass may therefore play a fundamental role in altering glucose homeostasis including metabolic dysregulation of insulin stimulated glucose uptake and may contribute to the development of metabolic disorders later in life.[37] Low lean mass has also been found to be the strongest risk factors for metabolic syndrome in adults, independent of abdominal fat.[38] The mechanisms contributing to reduced insulin stimulated glucose uptake, impaired insulin signalling and action on lean mass are not fully understood. Increased accumulation of adipose tissue and intramuscular fat, dysregulated production of inflammatory adipokines, increased renin-angiotensin-aldosterone system activity, and decreased mitochondrial oxidative phosphorylation flux in the muscle have been suggested to play a significant role in the development of insulin resistance in lean mass.[37]

In addition, reduced subcutaneous fat may contribute to fat accumulation in other tissues and organs. Failure of fat cell formation in the subcutaneous fat compartment as body fat increases, might lead to storage of fat in tissues such as visceral adipose tissue, pancreas, muscle and liver.[39] This excess storage might contribute to the unfavourable distribution of abdominal fat and hepatic steatosis, as well as impaired insulin action resulting in insulin resistance, glucose intolerance and diabetes.[40]

Our results on cardiovascular and metabolic traits were not consistent across sex. Men who were stunted had higher HDL cholesterol levels, while stunted women had lower total cholesterol than the non-stunted ones. Previous analyses from the 1982 Pelotas (Brazil) birth cohort assessing associations with early stunting, defined using the 2006 WHO Child Growth Standards for height-for-age z score, showed mixed results, Nazmi et al. [41] found that men who were stunted at age 2 years and had abdominal obesity at age 23y had higher C-reactive protein levels, suggesting an increased risk for chronic diseases. Grillo et al. [13], studying metabolic syndrome components at adulthood (mean age 22.8 years), found that men and women who were stunted at age 2 years had lower triglycerides and women had lower HDL-cholesterol levels; however, these associations disappeared after adjustment for confounding variables. Buffarini et al.[42], using data from the 1982 and 1993 Pelotas (Brazil) birth cohorts, reported that those individuals who were stunted at age 1 had lower glycated haemoglobin in adolescents aged 18y, but not in adults aged 30 years. These discrepancies may be partly explained by excluding potential confounders like birth weight and or including mediating variables such as attained height and BMI to the analysis. These adjustments might potentially introduce bias because of inappropriate controlling.

We acknowledge some limitations of our study. Lipids and glucose levels were measured from non-fasting blood samples is our study; while HDL cholesterol is independent of fasting time [43], triglycerides are influenced by time of the day and fasting time.[44] However, new evidence suggests that the impact of fasting on lipids is modest [45]. We relied on ultrasound measurements of VFT and SAFT as proxies for these abdominal fat compartments. This technique has been found to correlate strongly with magnetic resonance imaging estimates of abdominal fat compartments in a variety of settings and populations using the same protocol, which was rigorously quality controlled.[46–48] We cannot rule out residual confounding, as we cannot exclude unmeasured genetic and environmental factors that may contribute to those associations.

To our knowledge, this is one of the largest reported samples with abdominal ultrasound measurements, and by far the largest from a low- or middle-income setting, which addressed the associations of early stunting with several cardiometabolic traits in adulthood. The prospective design of our study made it less susceptible to recall bias, as potential confounding variables were measured soon after delivery, and the higher follow-up rate of 68.1% at age 30 years is likely to reduce the chance of selection bias. The use of objective measurements/indicators of body composition is also a strength of this analysis.

In conclusion, our findings indicate that adults who had early childhood stunting may tend to accumulate less lean mass and subcutaneous fat, and may have a tendency to have a profile with higher visceral fat. This body composition profile, characterized by a preference to accumulate visceral fat rather than subcutaneous fat, might be deleterious to their future metabolic health. The current and previous reported findings derived from this cohort do not yet show evidence for increased biochemical markers of metabolic disease later into early adulthood, possibly because the cohort is still young to present marked alterations in the evaluated traits. Our findings of a worse adiposity profile associated with stunting in early childhood do not preclude, however, that further developments into negative cardiometabolic profiles may occur, thus warranting longer-term evaluations.

Supporting information

[Figure omitted. See PDF.]

S1 Table. Associations of stunting at age 2y with cardiometabolic traits at age 30y.

https://doi.org/10.1371/journal.pone.0192196.s001

(DOCX)

S2 Table. Associations of stunting at age 2y with glycated haemglobin, total cholesterol and HDL cholesterol at age 30y according to sex.

https://doi.org/10.1371/journal.pone.0192196.s002

(DOCX)

Acknowledgments

We thank all volunteers who participated in the study; the field epidemiology team for assisting with data collection, especially Ízola Nunes and Márcia Blank; Caroline Bortolotto, Marina Valença, Nathalia Peter, and Nathália Silva for assisting with ultrasound data cleaning; and Janaína Santos for assisting with data management.

Citation: De Lucia Rolfe E, de França GVA, Vianna CA, Gigante DP, Miranda JJ, Yudkin JS, et al. (2018) Associations of stunting in early childhood with cardiometabolic risk factors in adulthood. PLoS ONE 13(4): e0192196. https://doi.org/10.1371/journal.pone.0192196

References

1. DeBoer MD, Lima AA, Oria RB, Scharf RJ, Moore SR, Luna MA, et al. (2012) Early childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome? Nutr Rev 70: 642–653. pmid:23110643

2. Martins VJ, Toledo Florencio TM, Grillo LP, do Carmo PFM, Martins PA, Clemente AP, et al. (2011) Long-lasting effects of undernutrition. Int J Environ Res Public Health 8: 1817–1846. pmid:21776204

3. Md Onis, Branca F (2016) Childhood stunting: a global perspective. Maternal & Child Nutrition 12: 12–26.

4. Stewart CP, Iannotti L, Dewey KG, Michaelsen KF, Onyango AW (2013) Contextualising complementary feeding in a broader framework for stunting prevention. Matern Child Nutr 9: 27–45. pmid:24074316

5. Hoffman DJ, Sawaya AL, Verreschi I, Tucker KL, Roberts SB (2000) Why are nutritionally stunted children at increased risk of obesity? Studies of metabolic rate and fat oxidation in shantytown children from Sao Paulo, Brazil. Am J Clin Nutr 72: 702–707. pmid:10966887

6. Lanigan J, Singhal A (2009) Early nutrition and long-term health: a practical approach. Proc Nutr Soc 68: 422–429. pmid:19698202

7. Victora CG, Aquino EM, Leal MdC, Monteiro CA, Barros FC, Szwarcwald CL (2011) Maternal and child health in Brazil: progress and challenges. The Lancet 377: 1863–1876.

8. Matijasevich A, Santos IS, Menezes AMB, Barros AJD, Gigante DP, Horta BL, et al. (2012) Trends in socioeconomic inequalities in anthropometric status in a population undergoing the nutritional transition: data from 1982, 1993 and 2004 pelotas birth cohort studies. BMC Public Health 12.

9. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, et al. (2008) Maternal and child undernutrition: consequences for adult health and human capital. Lancet 371: 340–357. pmid:18206223

10. Ong KK, Hardy R, Shah I, Kuh D, National Survey of Health and Development Scientific and Data Collection Teams (2013) Childhood Stunting and Mortality Between 36 and 64 Years: The British 1946 Birth Cohort Study J Clin Endocrinol Metab 98: 2070–2077. pmid:23533234

11. Prendergast AJ, Humphrey JH (2014) The stunting syndrome in developing countries. Paediatr Int Child Health 34: 250–265. pmid:25310000

12. Horta BL, Victora CG, Mola CLd, Quevedo L, Pinheiro RT, Gigante DP, et al. (2017) Associations of Linear Growth and Relative Weight Gain in Early Life with Human Capital at 30 Years of Age. J Pediatr 182: 85–91. pmid:28063689

13. Grillo LP, Gigante DP, Horta BL, de Barros FC (2016) Childhood stunting and the metabolic syndrome components in young adults from a Brazilian birth cohort study. Eur J Clin Nutr 70: 548–553. pmid:26733042

14. França GVAd, De Lucia Rolfe E, Horta B, Gigante DP, Yudkin JS, Ong KK, et al. (2016) Associations of birth weight, linear growth and relative weight gain throughout life with abdominal fat depots in adulthood: the 1982 Pelotas (Brazil) birth cohort study. International Journal of Obesity 40: 14–21. pmid:26395747

15. Victora CG, Barros FC (2006) Cohort profile: the 1982 Pelotas (Brazil) birth cohort study. Int J Epidemiol 35: 237–242. pmid:16373375

16. Barros FC, Victora CG, Horta BL, Gigante DP (2008) [Methodology of the Pelotas birth cohort study from 1982 to 2004–5, Southern Brazil]. Rev Saude Publica 42 Suppl 2: 7–15.

17. Victora CG, Barros FC, Lima RC, Behague DP, Gon alves H, Horta BL, et al. (2003) The Pelotas birth cohort study, Rio Grande do Sul, Brazil, 1982–2001. Cad Saude Publica 19: 1241–1256. pmid:14666206

18. Horta BL, Gigante DP, Gonçalves H, Motta JVdS, Mola CLd, Oliveira IO, et al. (2015) Cohort Profile Update: The 1982 Pelotas (Brazil) Birth Cohort Study. Int J Epidemiol 44: 441–441e. pmid:25733577

19. de Onis M, Onyango AW (2008) WHO child growth standards. Lancet 371: 204. pmid:18207015

20. Siri WR (1961) Body composition from fluid spaces and density; analysis of methods. In: Brozek J, Henschel A, editors. Techniques for measuring body composition. Washington D.C.: Nat. Acad. Sci. pp. 223–244.

21. Linhares Rda S, Gigante DP, de Barros FC, Horta BL (2015) Carotid intima-media thickness at age 30, birth weight, accelerated growth during infancy and breastfeeding: a birth cohort study in Southern Brazil. PLoS One 10: e0115166. pmid:25611747

22. Hernán MA, Hernández-Díaz S, Robins JM (2004) A structural approach to selection bias. Epidemiology 15: 615–625. pmid:15308962

23. Bennett F, Watson-Brown C, Thame M, Wilks R, Osmond C, Hales N, et al. (2002) Shortness at birth is associated with insulin resistance in pre-pubertal Jamaican children. Eur J Clin Nutr 56: 506–511. pmid:12032649

24. Bennett FI, Walker SP, Gaskin P, Powell CA (2002) Fasting levels of serum glucose, cholesterol and triglyceride at age eleven to twelve years in stunted and non-stunted Jamaican children. Acta Paediatr 91: 903–908. pmid:12412863

25. Walker SP, Gaskin PS, Powell CA, Bennett FI (2002) The effects of birth weight and postnatal linear growth retardation on body mass index, fatness and fat distribution in mid and late childhood. Public Health Nutr 5: 391–396. pmid:12003649

26. Finelli C, Sommella L, Gioia S, Sala NL, Tarantino G (2013) Should visceral fat be reduced to increase longevity? Ageing Res Rev 12: 996–1004. pmid:23764746

27. Lebovitz HE, Banerji MA (2005) Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 28: 2322–2325. pmid:16123512

28. Hardy OT, Czech MP, Corvera S (2012) What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 19: 81–87. pmid:22327367

29. De Lucia Rolfe E, Ong KK, Sleigh A, Dunger DB, Norris SA (2015) Abdominal fat depots associated with insulin resistance and metabolic syndrome risk factors in black African young adults. BMC Public Health 15: 1013. pmid:26437649

30. Lovejoy JC, Smith SR, Rood JC (2001) Comparison of regional fat distribution and health risk factors in middle-aged white and African American women: The Healthy Transitions Study. Obes Res 9: 10–16. pmid:11346662

31. Waterlow JC (1999) The nature and significance of nutritional adaptation. Eur J Clin Nutr 53 Suppl 1: S2–5.

32. Shetty PS (1999) Adaptation to low energy intakes: the responses and limits to low intakes in infants, children and adults. Eur J Clin Nutr 53 Suppl 1: S14–33.

33. Kumari V, Abbas AK, Fusto N, Aster JC (2010) Environmental and Nutritional Diseases. Robbins and Robbins & Cotran Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders Elsevier. pp. 438–443.

34. Rubin R, Strayer DE (2008) Environmental and nutritional pathology. Rubin’s Pathology: Clinicopathologic Foundations of Medicine Philadelphia: Lippincott Williams &Wilkins. pp. 277–278.

35. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization. Diabetes 30: 1000–1007. pmid:7030826

36. Baron AD, Brechtel G, Wallace P, Edelman SV (1988) Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 255: E769–774. pmid:3059816

37. Park BS, Yoon JS (2013) Relative Skeletal Muscle Mass Is Associated with Development of Metabolic Syndrome. Diabetes Metab J 37: 458–464. pmid:24404517

38. Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA (2009) Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism 58: 1013–1022. pmid:19394973

39. Pasarica M, Xie H, Hymel D, Bray G, Greenway F, Ravussin E, et al. (2009) Lower Total Adipocyte Number but No Evidence for Small Adipocyte Depletion in Patients With Type 2 Diabetes. Diabetes Care 32: 900–902. pmid:19228873

40. Kursawe R, Eszlinger M, Narayan D, Liu T, Bazuine M, Cali AMG, et al. (2010) Cellularity and Adipogenic Profile of the Abdominal Subcutaneous Adipose Tissue From Obese Adolescents: Association With Insulin Resistance and Hepatic Steatosis. Diabetes 59: 2288–2296. pmid:20805387

41. Nazmi A, Gonzalez DC, Oliveira IO, Horta BL, Gigante DP, Victora CG (2009) Life course weight gain and C-reactive protein levels in young adults: findings from a Brazilian birth cohort. Am J Hum Biol 21: 192–199. pmid:19107921

42. Buffarini R, Restrepo-Méndez MC, Silveira VM, Miranda JJ, Gonçalves HD, Oliveira IO, et al. (2016) Distribution of Glycated Haemoglobin According to Early-Life and Contemporary Characteristics in Adolescents and Adults without Diabetes: The 1982 and 1993 Pelotas Birth Cohorts. PLoS ONE 11: e0162614. pmid:27626274

43. Craig SR, Amin RV, Russell DW, Paradise NF (2000) Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J Gen Intern Med 15: 395–399. pmid:10886474

44. Folsom AR, Kuba K, Leupker RV, Jacobs DR, Frantz ID (1983) Lipid concentrations in serum and EDTA-treated plasma from fasting and nonfasting normal persons, with particular regard to high-density lipoprotein cholesterol. Clinical Chemistry 29: 505–508. pmid:6402325

45. Mora S (2016) Nonfasting for Routine Lipid Testing: From Evidence to Action. JAMA Intern Med 176: 1005–1006. pmid:27119719

46. De Lucia Rolfe E, Sleigh A, Finucane FM, Brage S, Stolk RP, Cooper C, et al. (2010) Ultrasound Measurements of Visceral and Subcutaneous Abdominal Thickness to Predict Abdominal Adiposity Among Older Men and Women. Obesity 18: 625–631. pmid:19779473

47. De Lucia-Rolfe E, Norris SA, Sleigh A, Brage S, Dunger DB, Stolk RP, et al. (2011) Validation of Ultrasound Estimates of Visceral Fat in Black South African Adolescents. Obesity 19: 1892–1897. pmid:21738240

48. Stolk RP, Wink O, Zelissen PM, Meijer R, Gils APv, Grobbee DE (2001) Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 25: 1346–1351. pmid:11571598